Orbis Research has added “Parkinson Disease-Market Insights, Epidemiology and Market Forecast-2023-Japan”Report to its Comprehensive Database. The Report is a Brilliant Assessment of Emerging Therapies, Clinical Development and Clinical Pipeline Activity for Major Pipeline Drugs.
“Parkinson Disease Market Insights, Epidemiology and Market Forecast – 2023 Japan” Reports provides an overview of the disease and global market size of the Parkinson Disease for the Japan. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Parkinson Disease from 2010-2023.
According to Publisher, the forecasted patient population of Parkinson Disease will increase at a CAGR of XX% from 2010 to 2023 and the worldwide Parkinson Disease market is estimated to be USD XX Million by 2023.
Request a Sample of the Report at: http://www.orbisresearch.com/contacts/request-sample/209393
Parkinson’s disease (PD) is a disorder caused by the malfunction and death of neurons. It is a chronic and progressive movement disorder which primarily affects neurons in substantia nigra area of the brain. Dopamine is usually responsible for the control and coordination process which is affected when the neuron malfunction and death occurs. As the disease progresses, the amount of dopamine produced in the brain decreases as a result the person is unable to control movement normally. This degenerative disorder affects the central nervous system.
Scope of Parkinson Disease Report:
- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details.
- The Report also covers the detailed global historical and forecasted epidemiological data covering Japan from 2010-2023.
- It also provides Market size of Parkinson disease for Japan from 2010 and forecasted Market size to 2023
- Azilect: Teva Pharmaceutical Industries
- Exelon/Exelon Patch: Novartis
- Stalevo: Orion Corporation
- Comtan/Comtess: Orion Corporation
Major Pipeline drugs:
Buy the Report at: http://www.orbisresearch.com/contact/purchase/209393
Table of Contents:
- Global Parkinson Disease: Country-Wise Market Analysis
- Overview on Total Parkinson Disease Market (2015 & 2023)
- Japan Market Size
- Market Drivers
- Market Restraints
- Total Market Size of Parkinson Disease for 7 MM in 2013-2023
- Total Market Share Distribution of Parkinson Disease for 7 MM in 2015
- Total Market Share Distribution of Parkinson Disease for 7 MM in 2023
… and Continued
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch